piw
04 Nov 2019
Video: PHD FY19 results PHD FY19 results overview by Tim Sykes, CEO. (Following last week’s results.) piworld.co.uk Proactis (PHD) FY19 results overview November 2019 Tim Sykes, CEO, tells us the outcome of the operational review, how this is being executed, and what impact it will have going forward. Overview & operational r
piw
10 May 2019
Video: PHD H1 2019 results Tim Sykes, CEO presents H1 2019 results. piworld.co.uk Proactis (PHD) H1 2019 results presentation CEO, Tim Sykes talks us through interim results for the period ending 31st January 2019 PROACTIS Holdings PLC is a United Kingdom-based company, which is a Spend co c.50 mins Tim covers the financial highlights, the challenges, debt and cashflow, and the strategy going forward. A detailed authentic presentation where he owns up the problems, but equally indicates the solution.
piw
29 Apr 2019
PHD results and Strategic overview Video: A results overview and strategy update by Tim Sykes, CEO. Link above works, or watch on piworld: piworld.co.uk Proactis (PHD) Interim results & strategy review April 2019 Tim Sykes, CEO, gives an overview of the interim results for the period ending 31st January 2019, further he outlines the strategic review highlights, and how PHD a
Apocryphal_Now
28 Feb 2019
Trading update Well, the market really doesn’t like that trading update… Will the removal of Hamp Wall turn things around?
piw
30 Oct 2018
PHD FY results overview by Hamp Wall, CEO Procatis CEO, Hamp Wall, talks about the company’s full year results for the year ending 31st July 2018. piworld.co.uk Proactis (PHD) Full year results Y/E 31st July 2018 Procatis CEO Hamp Wall, talks about the company's full year results for the year ending 31st July 2018. Introduction - 00:21 Performance - 01:12 Growth Strategy - Introduction – 00:21 Performance – 01:12 Growth Strategy – 02:36 Summary & Outlook – 04:24
gretel
05 Jun 2018
CFO buys PHD shares Interesting to see hidden away in today's RNS that the CFO has acquired a further 10k shares - not a huge amount, but then the CFO/FD is always the lowest-paid exec by far on the Board, so such purchases are generally more meaningful than others:[link]
gretel
31 May 2018
Tipped in today's Shares Mgaazine Nice article, with PHD as one of their "Great Ideas". PHD is a "value opportunity" which "could deliver 65% share price upside over the next 12 to 18 months, perhaps more".It concludes:"Yet underlying key performance indicators remain encouraging. The company added 35 new customers accounts during the first half, keeping it on track with full year70 targets, and most of those (31) are on a subscription basis, which typically are more sticky.Proactis is also upselling impressively, getting existing clients to spend more over the platform. The company reported 46 in the first half this year, versusits 100 a year goal. It has £47.8m of forward orders backed up.This gives us confidence that management can affect a rapid operating improvement as the company moves forward, and that should become reflected in the share price as investor confidence returns. FinnCap retains its 250p 12-month target for the stock."
gretel
29 May 2018
Re: RNS : institutional buying From Citywire this morning:[link] (PHD)Who’s trading? Citywire AAA-rated Mark NiznikThe trade: Manager of the Artemis UK Smaller Companies fund has increased his stake in software company Proactis from 8.5% to 10.4% of the shares worth £11.6 million at a share price of 120.9p.How have the shares performed? Proactis plunged by almost 40% in one day on 24 April on the back of its interim results. It is down 42% from a 52-week high of 207p. What does the company say? In August 2017 the group started a restructuring plan, following an acquisition which was expected to deliver £5 million in annualised cost savings. While the pound’s resurgence impacted the company’s performance in the US and Europe, revenue was still up 124% to £26.4 million in the six months to 31 January. What’s the outlook? In a report following the results analysts at N+1 Singer reiterated their ‘buy’ rating on the stock, with a price target of 189p. Meanwhile analysts at FinnCap underlined some of the challenges in the business, but pointed out that this was just a bump in the road, retaining a share price target of 250p."
Red Ninja
24 May 2018
Re: RNS : institutional buying Artemis Investment Management LLP on behalf of discretionary funds under management has taken it's holding from 8.52 % to 13.38 %
gretel
22 May 2018
News - contract win with Giant Eagle Sounds impressive. Giant Eagle have around $10 billion of annual sales:[link] Eagle Partners with PROACTIS to Enhance its Private Brand Sourcing StrategyGiant Eagle to expand and improve its supplier network with PROACTIS Sourcing ServicesPROACTIS, a global Spend Control and eProcurement solution provider, today announced a partnership with Giant Eagle, Inc. as its strategic sourcing partner for the company’s private brands.Giant Eagle, Inc. is one of the nation’s leading food, fuel and pharmacy retailers with more than 400 supermarket and convenience store locations. It selected PROACTIS to enhance its Giant Eagle brands program by improving and extending its current supplier network communications to ensure that it continues to deliver the best in quality and value for its customers.After evaluating PROACTIS’ Sourcing Services through a proof of concept program offered by PROACTIS, Giant Eagle found that the managed services approach would maximise the efforts of its internal team and promote best practice that will ensure the Giant Eagle brand program is among the best in the industry.“enhancing our internal team with PROACTIS Sourcing Services, we will be able to dramatically increase the number of current and prospective suppliers we communicate with, ensuring that our customers only get the best when purchasing our Giant Eagle brand products,” said Brooke Hodierne, Senior Director of Own Brands. “With PROACTIS, my team will be freed up from the tactical time-consuming activities and can focus on other key initiatives.”As a strategic sourcing partner, PROACTIS’ managed service approach supplements Giant Eagle’s current process to sourcing private brands by working side-by-side with the retailer’s Procurement team. PROACTIS provides value for the Giant Eagle team by creating and running its private brand sourcing events.“We are proud of the trust Giant Eagle has placed in us,” stated Len Kaplan, Vice President Managed Sourcing Sales at PROACTIS. “It is a testament to our experience and ability to increase customer value by scaling internal procurement teams with our experts to maximise performance.”
gretel
18 May 2018
Re: RNS : institutional buying Strategic Equity Capital continue to buy - they're now above 6%, with 5.59m shares:[link]
Red Ninja
17 May 2018
Re: RNS : institutional buying Looks like another 2.7 million traded at 17p. Probably buys ?
Red Ninja
16 May 2018
Artemis Aim VCT Comment For April from their website [link] "Commentary"In contrast to recent history, the updates we received in April were, in the main, disappointing. Although interim results from Proactis were in line with expectations, a combination of currency headwinds and customer attrition meant that full-year forecasts were downgraded. We think the 42% fall in its share price was an overreaction but coming so soon after a large acquisition and fundraising we can sympathise with investors' frustrations. The management certainly has work to do if it is to restore confidence.
gretel
15 May 2018
RNS : institutional buying Strategic Equity Capital are buying more - they're now up to 5.8% (from 4.34%), with almost 5.4m shares:[link]
gretel
08 May 2018
Re: New forecasts from N+1 Singer Apologies, I picked up the wrong line for the EPS figures. Here's a revised post with the correct figures.....N+1 Singer have today revised their forecasts downwards following the warning, and have re-set their target price to 151p.Their new forecasts are: this year (to 31 July'18) : 9.1p EPS next year (to 31 July'19) : 11.3p EPSwith 1.5p and 1.6p dividends respectively.So we are only 3 months away from a year where the current year P/E will be just 9.5.They conclude: "Investor sentiment has been badly dented by the rapid reversal in outlook and given rise to concerns over customer retention and competitive positioning. However, there are enough indications that this weakness is temporal and the current valuation suggests significant upside if positive momentum is restored in Q4. We set a new target price of 151p."
